Lung Cancer Strategies for Diagnosis and Treatment

Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors,...

Full description

Saved in:
Bibliographic Details
Other Authors: Fabiola Costa Torres, Alba (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2018
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_130206
005 20231201
003 oapen
006 m o d
007 cr|mn|---annan
008 20231201s2018 xx |||||o ||| 0|eng d
020 |a intechopen.71993 
020 |a 9781789843507 
020 |a 9781789843491 
020 |a 9781838816391 
040 |a oapen  |c oapen 
024 7 |a 10.5772/intechopen.71993  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Fabiola Costa Torres, Alba  |4 edt 
700 1 |a Fabiola Costa Torres, Alba  |4 oth 
245 1 0 |a Lung Cancer  |b Strategies for Diagnosis and Treatment 
260 |b IntechOpen  |c 2018 
300 |a 1 electronic resource (204 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a immunotherapy, biomarker, metabolomics, epigenetic, cancer stem cells, methylation 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/6676/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/130206  |7 0  |z DOAB: description of the publication